Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, May 2013

Sort by: Newest first Oldest first A-Z Z-A

  • EU flag

    Cross-border healthcare proposals should not overburden pharmacists Subscription

    31 MAY 2013 14:49

    The Government should ensure that community pharmacy is not burdened by cross-border healthcare procedures, according to Pharmacy Voice.

  • Tamiflu stocks could be preserved if standard doses are prescribed during a pandemic

    Double dose of Tamiflu does not improve outcomes Subscription

    31 MAY 2013 14:44

    Doubling the approved dose of oseltamivir for the treatment of severe influenza does not improve outcomes, a study conducted by researchers in South East Asia has found (BMJ, 31 May 2013).

  • Pharmacists key stakeholders in opiate substitution therapy Subscription

    31 MAY 2013 14:39

    Community pharmacists should be seen as key stakeholders in opiate substitution therapy, Community Pharmacy Scotland has told a Scottish Government review.

  • Hospital signpost (Devonsun |

    Probiotics reduce diarrhoea linked to C difficile Subscription

    31 MAY 2013 14:29

    Probiotics are both safe and effective at reducing Clostridium difficile-associated diarrhoea (CDAD) in patients taking antibiotics, concludes a systematic review (Cochrane Database of Systematic Reviews 2013, issue 5).

  • Cigarettes and stub (S-dmit/|

    Combination NRT and varenicline best drugs for smoking cessation Subscription

    31 MAY 2013 14:15

    Combination nicotine replacement therapy and varenicline are the two most effective pharmacological interventions for smoking cessation, according to a systematic review (Cochrane Database of Systematic Reviews 2013, issue 5).

  • New draft clinical trial rules backed by MEPs Subscription

    31 MAY 2013 14:11

    The European Parliament’s public health committee has endorsed new draft EU rules simplifying procedures for clinical trials.

  • Medicines to be focus of next WHO safety challenge Subscription

    31 MAY 2013 14:08

    Medicines safety is to be the focus of the next World Health Organization global patient safety challenge, it was announced last week (24 May 2013).

  • Eye chart  (Christophe Testi/

    Restrict retigabine use due to retinal pigmentation risk Subscription

    31 MAY 2013 13:52

    GlaxoSmithKline’s anti-epileptic medicine retigabine (Trobalt) should be restricted to patients for whom other medicines are inadequate or not tolerated, according to new advice from the European Medicines Agency’s Committee for Medicinal Products for Human Use.

  • Illustration of a heart (Sebastian Kaulitzki/

    New analysis highlights CV risks with diclofenac and ibuprofen Subscription

    30 MAY 2013 15:27

    High-dose diclofenac increases the risk of cardiovascular events by almost a third, a risk similar to that associated with use of selective cyclo-oxygenase 2 inhibitors (coxibs), according to research published today in The Lancet (online, 30 May 2013).

  • New remuneration structure on the cards in Scotland Subscription

    30 MAY 2013 12:59

    A new remuneration structure for community pharmacy in Scotland is likely to be introduced later this year (2013), if Scottish Government plans go ahead. This is part of a continued move away from payment by dispensing volume.

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.